Eortc PowerPoint PPT Presentations

All Time
Show:
Recommended
Sort by:
Tumor tissue bank creation within EORTC network Ivana Teodorovic, MD, MSc, Tumor Bank Unit, EORTC Da PowerPoint PPT Presentation
Tumor tissue bank creation within EORTC network Ivana Teodorovic, MD, MSc, Tumor Bank Unit, EORTC Da - EORTC. Tumor tissue bank creation within EORTC network ... To improve and harmonize histology review across EORTC trials (quality of research) ...
EORTC. Tumor tissue bank creation within EORTC network ... To improve and harmonize histology review across EORTC trials (quality of research) ...
| PowerPoint PPT presentation | free to view
EORTC Tumor Bank PowerPoint PPT Presentation
EORTC Tumor Bank - To standardize and support histology review across EORTC trials (quality of research) ... and Data Flowchart during histology review. EORTC. EORTC Tumor Bank ...
To standardize and support histology review across EORTC trials (quality of research) ... and Data Flowchart during histology review. EORTC. EORTC Tumor Bank ...
| PowerPoint PPT presentation | free to view
EORTC Virtual Tumor Bank VTB PowerPoint PPT Presentation
EORTC Virtual Tumor Bank VTB - Tumor Bank Steering Committee, which is composed of representatives of the EORTC ... King Lam, EORTC Pathology sub-committee group for Telematics, chairman ...
Tumor Bank Steering Committee, which is composed of representatives of the EORTC ... King Lam, EORTC Pathology sub-committee group for Telematics, chairman ...
| PowerPoint PPT presentation | free to view
CLASSIFICAZIONE DELLA DISABILITA PowerPoint PPT Presentation
CLASSIFICAZIONE DELLA DISABILITA - ... (CALGB e EORTC) stabiliscono delle commissioni per lo studio della Qualit di Vita RIABILITAZIONE definizione (1) Rehabilitation broadly conceived, ...
... (CALGB e EORTC) stabiliscono delle commissioni per lo studio della Qualit di Vita RIABILITAZIONE definizione (1) Rehabilitation broadly conceived, ...
| PowerPoint PPT presentation | free to download
PowerPointPrsentation PowerPoint PPT Presentation
PowerPointPrsentation - the Infectious Diseases Group of the EORTC ... Thanks to Marianne Paesmans, EORTC Data Center, for data collection and analysis ...
the Infectious Diseases Group of the EORTC ... Thanks to Marianne Paesmans, EORTC Data Center, for data collection and analysis ...
| PowerPoint PPT presentation | free to view
Aucun titre de diapositive PowerPoint PPT Presentation
Aucun titre de diapositive - ... Caryotype oncologique: Biologie mol culaire: non faite Immunoph notypage: sur sang et moelle non fait EORTC (essai n 58881) haut risque ...
... Caryotype oncologique: Biologie mol culaire: non faite Immunoph notypage: sur sang et moelle non fait EORTC (essai n 58881) haut risque ...
| PowerPoint PPT presentation | free to view
Response Evaluation: Beyond RECIST PowerPoint PPT Presentation
Response Evaluation: Beyond RECIST - The word 'response' is used in a number of contexts: ... fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. ...
The word 'response' is used in a number of contexts: ... fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. ...
| PowerPoint PPT presentation | free to view
Randomized phase III study of neoadjuvant chemotherapy followed by surgery vs concomitant radiothera PowerPoint PPT Presentation
Randomized phase III study of neoadjuvant chemotherapy followed by surgery vs concomitant radiothera - ... followed by surgery vs concomitant radiotherapy and chemotherapy in FIGO ... Number of randomized patients required: 686. EORTC 55994. Eligibility criteria. 55994 ...
... followed by surgery vs concomitant radiotherapy and chemotherapy in FIGO ... Number of randomized patients required: 686. EORTC 55994. Eligibility criteria. 55994 ...
| PowerPoint PPT presentation | free to download
Results PowerPoint PPT Presentation
Results - transfusions and use of growth factors. 2004 International ... New Zealand), EORTC (Europe), GEICO (Spain), GINECO (France), NSGO (Scandinavia), JGOG (Japan) ...
transfusions and use of growth factors. 2004 International ... New Zealand), EORTC (Europe), GEICO (Spain), GINECO (France), NSGO (Scandinavia), JGOG (Japan) ...
| PowerPoint PPT presentation | free to download
Study proposal PowerPoint PPT Presentation
Study proposal - ... a trial propulation with somewhat more advanced cases than in NSGO/EORTC/MANGO ... clinical trials in endometrial cancer! CONTACT INFORMATION. Thomas Hogberg ...
... a trial propulation with somewhat more advanced cases than in NSGO/EORTC/MANGO ... clinical trials in endometrial cancer! CONTACT INFORMATION. Thomas Hogberg ...
| PowerPoint PPT presentation | free to view
Introduction NDA 20449SE011 PowerPoint PPT Presentation
Introduction NDA 20449SE011 - Two large Phase 3 trials: ... Taxotere 100 mg/m2, one-hour IV infusion on Day 1, every 21 days Premedication: ... Both the LCSS and EORTC instruments were used. ...
Two large Phase 3 trials: ... Taxotere 100 mg/m2, one-hour IV infusion on Day 1, every 21 days Premedication: ... Both the LCSS and EORTC instruments were used. ...
| PowerPoint PPT presentation | free to view
Kein Folientitel PowerPoint PPT Presentation
Kein Folientitel - Randomised EORTC-GCG/NCIC-CTG trial on NACT IDS versus PDS. Surgical characteristics (PP1) ... no bulky lymph nodes. Endpoints: OS, PFS, QoL Strata: centre, PS ,age ...
Randomised EORTC-GCG/NCIC-CTG trial on NACT IDS versus PDS. Surgical characteristics (PP1) ... no bulky lymph nodes. Endpoints: OS, PFS, QoL Strata: centre, PS ,age ...
| PowerPoint PPT presentation | free to view
CLOCC TRIAL PowerPoint PPT Presentation
CLOCC TRIAL - An EORTC Trial being run in the UK by the NCRI Colorectal Cancer Sub-Group ... 5FU 400mg/m2 bolus. 5FR 2400mg/m2 46h iv infusion - 2 weekly for 6 months ie. 12 courses ...
An EORTC Trial being run in the UK by the NCRI Colorectal Cancer Sub-Group ... 5FU 400mg/m2 bolus. 5FR 2400mg/m2 46h iv infusion - 2 weekly for 6 months ie. 12 courses ...
| PowerPoint PPT presentation | free to view
A1258690667otspz PowerPoint PPT Presentation
A1258690667otspz - Early treatment of relapsed ovarian cancer based on CA125 level alone. versus ... MRC OV05 and EORTC 55955 trials. Gordon Rustin (Mount Vernon Cancer Centre) ...
Early treatment of relapsed ovarian cancer based on CA125 level alone. versus ... MRC OV05 and EORTC 55955 trials. Gordon Rustin (Mount Vernon Cancer Centre) ...
| PowerPoint PPT presentation | free to download
C???????????: PowerPoint PPT Presentation
C???????????: - Title:
Title:
| PowerPoint PPT presentation | free to download
Radioth PowerPoint PPT Presentation
Radioth - Radioth
Radioth
| PowerPoint PPT presentation | free to view
Post-operative Radiation Therapy following Radical Prostatectomy for Prostate Cancer PowerPoint PPT Presentation
Post-operative Radiation Therapy following Radical Prostatectomy for Prostate Cancer - Post-operative Radiation Therapy following Radical Prostatectomy for Prostate Cancer Stephen Ko, M.D. Mayo Clinic Jacksonville Prostate Cancer One third of patients ...
Post-operative Radiation Therapy following Radical Prostatectomy for Prostate Cancer Stephen Ko, M.D. Mayo Clinic Jacksonville Prostate Cancer One third of patients ...
| PowerPoint PPT presentation | free to download
Patient-Reported Outcomes: Introducion and Overview PowerPoint PPT Presentation
Patient-Reported Outcomes: Introducion and Overview - Title: Patient adherence to highly active antiretroviral therapy Author: PCLAN Last modified by: Pythia Created Date: 3/3/2000 5:43:32 PM Document presentation format
Title: Patient adherence to highly active antiretroviral therapy Author: PCLAN Last modified by: Pythia Created Date: 3/3/2000 5:43:32 PM Document presentation format
| PowerPoint PPT presentation | free to view
Do we need post-operative CHEMOTHERAPY in patients with PATHOLOGIC Complete Response to neoadjuvant therapy in RECTAL CANCER ? PowerPoint PPT Presentation
Do we need post-operative CHEMOTHERAPY in patients with PATHOLOGIC Complete Response to neoadjuvant therapy in RECTAL CANCER ? - Do we need post-operative CHEMOTHERAPY in patients with PATHOLOGIC Complete Response to neoadjuvant therapy in RECTAL CANCER ? Philippe Rougier
Do we need post-operative CHEMOTHERAPY in patients with PATHOLOGIC Complete Response to neoadjuvant therapy in RECTAL CANCER ? Philippe Rougier
| PowerPoint PPT presentation | free to download
Chapter 8 Quality of Life Assessment PowerPoint PPT Presentation
Chapter 8 Quality of Life Assessment - Chapter 8 Quality of Life Assessment
Chapter 8 Quality of Life Assessment
| PowerPoint PPT presentation | free to view
TUMEURS CEREBRALES primitives de l PowerPoint PPT Presentation
TUMEURS CEREBRALES primitives de l - TUMEURS CEREBRALES primitives de l Adulte Pr E. Cohen-Jonathan Moyal Epid miologie Repr sente moins de 5% de l ensemble des cancers 80% localis s enc phale ...
TUMEURS CEREBRALES primitives de l Adulte Pr E. Cohen-Jonathan Moyal Epid miologie Repr sente moins de 5% de l ensemble des cancers 80% localis s enc phale ...
| PowerPoint PPT presentation | free to download
Soft Tissue Sarcoma (STS) are a group of highly chemotherapy resistant tumors PowerPoint PPT Presentation
Soft Tissue Sarcoma (STS) are a group of highly chemotherapy resistant tumors - Title: Slide 1 Author: David Haen Last modified by: Brian Created Date: 9/30/2004 7:32:02 PM Document presentation format: (4:3) Company
Title: Slide 1 Author: David Haen Last modified by: Brian Created Date: 9/30/2004 7:32:02 PM Document presentation format: (4:3) Company
| PowerPoint PPT presentation | free to download
Endometrial Committee PowerPoint PPT Presentation
Endometrial Committee - Director and Dallas Foundation Chair in Gynecologic Oncology ... medroxy progesterone 200 mg. or. megestrol 160 mg (as per local practice) po daily ...
Director and Dallas Foundation Chair in Gynecologic Oncology ... medroxy progesterone 200 mg. or. megestrol 160 mg (as per local practice) po daily ...
| PowerPoint PPT presentation | free to view
Adjuvant Therapy for Melanoma What is the role of PegIFN in relation to HDIFN? PowerPoint PPT Presentation
Adjuvant Therapy for Melanoma What is the role of PegIFN in relation to HDIFN? - Adjuvant Therapy for Melanoma What is the role of PegIFN in relation to HDIFN? John M. Kirkwood, MD Professor of Medicine, Dermatology and Translational Science
Adjuvant Therapy for Melanoma What is the role of PegIFN in relation to HDIFN? John M. Kirkwood, MD Professor of Medicine, Dermatology and Translational Science
| PowerPoint PPT presentation | free to download
PCR-where have we gone? PowerPoint PPT Presentation
PCR-where have we gone? - Early diagnosis of the infection may be improved if ... Mort. 30 days. IFI in treated. AF therapy. IFI proven/ probable. 15 candidiasis, 8 aspergillosis, ...
Early diagnosis of the infection may be improved if ... Mort. 30 days. IFI in treated. AF therapy. IFI proven/ probable. 15 candidiasis, 8 aspergillosis, ...
| PowerPoint PPT presentation | free to view
Optimizing Chemotherapy for Malignant Glioma State of the Art PowerPoint PPT Presentation
Optimizing Chemotherapy for Malignant Glioma State of the Art - ... RT and TMZ in vitro. Continuous administration of TMZ feasible, increases ... TMZ 75 mg/m2 daily (7 days per week) from day 1 of RT until last day of RT (max ...
... RT and TMZ in vitro. Continuous administration of TMZ feasible, increases ... TMZ 75 mg/m2 daily (7 days per week) from day 1 of RT until last day of RT (max ...
| PowerPoint PPT presentation | free to view
GIST: Adjuvante Studien, PowerPoint PPT Presentation
GIST: Adjuvante Studien, - The impact of operative techniques to the onset of peritoneal tumor dissemination in patients with uterine leiomyosarcomas Franka Menge, Eva Hartmann, Monika Mathew ...
The impact of operative techniques to the onset of peritoneal tumor dissemination in patients with uterine leiomyosarcomas Franka Menge, Eva Hartmann, Monika Mathew ...
| PowerPoint PPT presentation | free to download
PowerPoint PPT Presentation
- i. ( , ) ...
i. ( , ) ...
| PowerPoint PPT presentation | free to download
PowerPoint PPT Presentation
- Lymphocytic Cutaneous Infiltration Reactive ? , Pseudo ...
Lymphocytic Cutaneous Infiltration Reactive ? , Pseudo ...
| PowerPoint PPT presentation | free to download
PowerPointPrsentation PowerPoint PPT Presentation
PowerPointPrsentation - Epidemiological data in the mid 80' Development of resistance to glycopeptides in 90' ... 598 Pts afebrile, or with exclusion criteria for randomization. RANDOMIZATION ...
Epidemiological data in the mid 80' Development of resistance to glycopeptides in 90' ... 598 Pts afebrile, or with exclusion criteria for randomization. RANDOMIZATION ...
| PowerPoint PPT presentation | free to view
Diapositiva 1 PowerPoint PPT Presentation
Diapositiva 1 - Controversie nella biopsia del linfonodo sentinella nel melanoma R. Santoni M. Framarini GM Verdecchia New avenues of sentinel node staging ...
Controversie nella biopsia del linfonodo sentinella nel melanoma R. Santoni M. Framarini GM Verdecchia New avenues of sentinel node staging ...
| PowerPoint PPT presentation | free to download
The extent of use and preference of a suitable HRQoL instrument for routine clinical use in head PowerPoint PPT Presentation
The extent of use and preference of a suitable HRQoL instrument for routine clinical use in head - Health-related quality of life (HRQoL) is an important end-point in oncology patients. ... Thornicroft and Slade, 2000) HRQoL workshop/Liverpool/ 2006. 11 ...
Health-related quality of life (HRQoL) is an important end-point in oncology patients. ... Thornicroft and Slade, 2000) HRQoL workshop/Liverpool/ 2006. 11 ...
| PowerPoint PPT presentation | free to view
Maladie de Hodgkin PowerPoint PPT Presentation
Maladie de Hodgkin - La conception du protocole r sulte de l'analyse des donn es concernant : ... apparent de la RT, si nombre ' appropri ' de cycles de chimioth rapie (CT) avec ...
La conception du protocole r sulte de l'analyse des donn es concernant : ... apparent de la RT, si nombre ' appropri ' de cycles de chimioth rapie (CT) avec ...
| PowerPoint PPT presentation | free to view
CHEMOTHERAPY FOR ADVANCED TESTICULAR GERMCELL TUMORS PowerPoint PPT Presentation
CHEMOTHERAPY FOR ADVANCED TESTICULAR GERMCELL TUMORS - Absence of non-pulmonary. visceral metastasis and. AFP 1000 ng/ml and ... visceral metastasis and. 1000 AFP 10,000 ng/ml or. 5000 hCG 50,000 UI/ml or ...
Absence of non-pulmonary. visceral metastasis and. AFP 1000 ng/ml and ... visceral metastasis and. 1000 AFP 10,000 ng/ml or. 5000 hCG 50,000 UI/ml or ...
| PowerPoint PPT presentation | free to view
Understanding Testicular Cancer: A MUST for the Medical Oncologist PowerPoint PPT Presentation
Understanding Testicular Cancer: A MUST for the Medical Oncologist - Understanding Testicular Cancer: A MUST for the Medical Oncologist Jorge A. Garcia, MD., FACP. Associate Professor Medicine Director, Advanced Prostate Cancer Program
Understanding Testicular Cancer: A MUST for the Medical Oncologist Jorge A. Garcia, MD., FACP. Associate Professor Medicine Director, Advanced Prostate Cancer Program
| PowerPoint PPT presentation | free to download
Survival in the United Kingdom Medical Research Council AML trials 1970 PowerPoint PPT Presentation
Survival in the United Kingdom Medical Research Council AML trials 1970 - Survival in the United Kingdom Medical Research Council AML trials 1970 1999 for patients aged 15 59 years
Survival in the United Kingdom Medical Research Council AML trials 1970 1999 for patients aged 15 59 years
| PowerPoint PPT presentation | free to download
The management of the patient with N2 involvement at mediastinoscopy PowerPoint PPT Presentation
The management of the patient with N2 involvement at mediastinoscopy - ... non-surgical treatments result in fitter patients who can tolerate more ... 'if there is any benefit to surgery it is very small and probably counterbalanced ...
... non-surgical treatments result in fitter patients who can tolerate more ... 'if there is any benefit to surgery it is very small and probably counterbalanced ...
| PowerPoint PPT presentation | free to view
Celine Bicquart Advanced Laryngeal Cancers PowerPoint PPT Presentation
Celine Bicquart Advanced Laryngeal Cancers - Title: Celine Bicquart Advanced Laryngeal Cancers Author: celine Last modified by: sanghvip Created Date: 10/11/2006 5:16:41 PM Document presentation format
Title: Celine Bicquart Advanced Laryngeal Cancers Author: celine Last modified by: sanghvip Created Date: 10/11/2006 5:16:41 PM Document presentation format
| PowerPoint PPT presentation | free to view
Neoadjuvant Chemoradiotherapy for Rectal Cancer PowerPoint PPT Presentation
Neoadjuvant Chemoradiotherapy for Rectal Cancer - Invasion of mesorectal fascia. Staging workup. Physical Exam. Colonoscopy ... OR whether LN's are within or outside mesorectal fascia ...
Invasion of mesorectal fascia. Staging workup. Physical Exam. Colonoscopy ... OR whether LN's are within or outside mesorectal fascia ...
| PowerPoint PPT presentation | free to view
J Peter Donnelly PowerPoint PPT Presentation
J Peter Donnelly - J Peter Donnelly
J Peter Donnelly
| PowerPoint PPT presentation | free to view
PRACTICE CHANGING BIG PowerPoint PPT Presentation
PRACTICE CHANGING BIG - PRACTICE CHANGING BIG
PRACTICE CHANGING BIG
| PowerPoint PPT presentation | free to view
Assessment of quality of life of patients with gastric cancer after surgery: PowerPoint PPT Presentation
Assessment of quality of life of patients with gastric cancer after surgery: - Gastrectomy . Stomach neoplasm Limits of ... The functional effect of an illness and its consequent therapy upon a ... Systematic review Target ...
Gastrectomy . Stomach neoplasm Limits of ... The functional effect of an illness and its consequent therapy upon a ... Systematic review Target ...
| PowerPoint PPT presentation | free to view
BR.21 schema PowerPoint PPT Presentation
BR.21 schema - BR.21 schema TarcevaTM 150mg daily RANDOM I SE* Stratified by Centre PS (0/1 vs 2/3) Response prior Rx (CR/PR:SD:PD) Prior regimens (1 vs 2) Prior platinum
BR.21 schema TarcevaTM 150mg daily RANDOM I SE* Stratified by Centre PS (0/1 vs 2/3) Response prior Rx (CR/PR:SD:PD) Prior regimens (1 vs 2) Prior platinum
| PowerPoint PPT presentation | free to download
A QUALITY OF LIFE (QOL) QUESTIONNAIRE, CARE NOTEBOOK, FOR CANCER PATIENTS USING OUTPATIENT CLINIC. PowerPoint PPT Presentation
A QUALITY OF LIFE (QOL) QUESTIONNAIRE, CARE NOTEBOOK, FOR CANCER PATIENTS USING OUTPATIENT CLINIC. - ... in the fields of daily clinic and palliative care, we had no tools to measure QOL. ... with cancer who were treated by both active treatment and palliative care. ...
... in the fields of daily clinic and palliative care, we had no tools to measure QOL. ... with cancer who were treated by both active treatment and palliative care. ...
| PowerPoint PPT presentation | free to view
Patient Advocate Symposium Neuro-Oncology Paul Brown, MD PowerPoint PPT Presentation
Patient Advocate Symposium Neuro-Oncology Paul Brown, MD - Patient Advocate Symposium Neuro-Oncology Paul Brown, MD Professor of Oncology Department of Radiation Oncology Mayo Clinic Rochester, MN Brain Cancers: Frequency ...
Patient Advocate Symposium Neuro-Oncology Paul Brown, MD Professor of Oncology Department of Radiation Oncology Mayo Clinic Rochester, MN Brain Cancers: Frequency ...
| PowerPoint PPT presentation | free to download
CALVET Laure. interne DES h PowerPoint PPT Presentation
CALVET Laure. interne DES h - Title: Beta 1,3D-glucane comme l ment diagnostique d une infection fongique Author: laure calvet Last modified by: laure calvet Created Date
Title: Beta 1,3D-glucane comme l ment diagnostique d une infection fongique Author: laure calvet Last modified by: laure calvet Created Date
| PowerPoint PPT presentation | free to view
AntiCD20 antibodies in the treatment of malignant lymphoma PowerPoint PPT Presentation
AntiCD20 antibodies in the treatment of malignant lymphoma - CHOP vs R-CHOP in DLBCL 60-80 years. Event-free survival: 4-year update ... Rituximab plus CHOP is now internationally accepted as the standard first line ...
CHOP vs R-CHOP in DLBCL 60-80 years. Event-free survival: 4-year update ... Rituximab plus CHOP is now internationally accepted as the standard first line ...
| PowerPoint PPT presentation | free to view
The Role Of Radiation Therapy In The High Risk Patient PowerPoint PPT Presentation
The Role Of Radiation Therapy In The High Risk Patient - 3D Conformal, IMRT, HDR Brachytherapy boost ... prostate HDR brachytherapy* EBRT: 36-50 Gy 1.8-2 Gy daily 5x per week. HDR brachytherapy: dose escalated ...
3D Conformal, IMRT, HDR Brachytherapy boost ... prostate HDR brachytherapy* EBRT: 36-50 Gy 1.8-2 Gy daily 5x per week. HDR brachytherapy: dose escalated ...
| PowerPoint PPT presentation | free to view
Dirk Arnold PowerPoint PPT Presentation
Dirk Arnold - New treatment options for colorectal cancer with XELIRI Dirk Arnold Martin Luther University Halle Wittenberg, Germany Evolving role of irinotecan combinations in ...
New treatment options for colorectal cancer with XELIRI Dirk Arnold Martin Luther University Halle Wittenberg, Germany Evolving role of irinotecan combinations in ...
| PowerPoint PPT presentation | free to view
Final Results of the Sunbelt Melanoma Trial PowerPoint PPT Presentation
Final Results of the Sunbelt Melanoma Trial - Randomized prospective trial. Eligible patients. Age 18-70 yrs ... Randomize. 1 Positive Node Only. IFN. Arm 2. N=106. RT-PCR Negative. RT-PCR Positive. PROTOCOL B ...
Randomized prospective trial. Eligible patients. Age 18-70 yrs ... Randomize. 1 Positive Node Only. IFN. Arm 2. N=106. RT-PCR Negative. RT-PCR Positive. PROTOCOL B ...
| PowerPoint PPT presentation | free to view
Liver Metastases in Colorectal Cancer: Current and Emerging Approaches to Treatment PowerPoint PPT Presentation
Liver Metastases in Colorectal Cancer: Current and Emerging Approaches to Treatment - Liver Metastases in Colorectal Cancer: Current and Emerging Approaches to Treatment
Liver Metastases in Colorectal Cancer: Current and Emerging Approaches to Treatment
| PowerPoint PPT presentation | free to view
Organ Preservation for Laryngeal Cancer PowerPoint PPT Presentation
Organ Preservation for Laryngeal Cancer - ... Society for Head and Neck Oncology ... Arch Otolaryngol Head Neck Surg/Vol 131, p819, Sept ... Archives of Otolaryngology Head and Neck Surgery Jul 2004. ...
... Society for Head and Neck Oncology ... Arch Otolaryngol Head Neck Surg/Vol 131, p819, Sept ... Archives of Otolaryngology Head and Neck Surgery Jul 2004. ...
| PowerPoint PPT presentation | free to view
Oncology Symposium Future development plans and strategies for the NCRI Anal cancer working group PowerPoint PPT Presentation
Oncology Symposium Future development plans and strategies for the NCRI Anal cancer working group - Association of Coloproctology of Great Britain and Ireland ... Prospectively examine persistent SUV at this time point. Could allow early surgical salvage. ...
Association of Coloproctology of Great Britain and Ireland ... Prospectively examine persistent SUV at this time point. Could allow early surgical salvage. ...
| PowerPoint PPT presentation | free to view
IL TRATTAMENTO INTEGRATO DELLE METASTASI POLMONARI PowerPoint PPT Presentation
IL TRATTAMENTO INTEGRATO DELLE METASTASI POLMONARI - Title: ECAS Update: Anemia in European Cancer Patients Last modified by: umberto Created Date: 6/30/2004 3:20:31 PM Document presentation format
Title: ECAS Update: Anemia in European Cancer Patients Last modified by: umberto Created Date: 6/30/2004 3:20:31 PM Document presentation format
| PowerPoint PPT presentation | free to view


Home About Us Terms and Conditions Privacy Policy Contact Us
Copyright 2025 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
eortc — Search results on PowerShow.com